Aandeel ABBV ABBVIE INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Bedrijfsvoering AbbVie Inc.

Aandelen

ABBV

US00287Y1091

Farmaceutische producten

Geschatte realtime Cboe BZX
Andere beurzen
 19:11:52 10-09-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
197,12 USD +0,36% Intraday-grafiek van AbbVie Inc. -0,32% +27,16%
09/09 AbbVie presenteert positieve gegevens voor prospectieve behandeling van eierstokkanker op aanstaande conferentie MT
09/09 Orderportefeuille CSC Holdings stijgt naar SG$320 miljoen; Aandelen stijgen met 14% MT

Uitvoerend comité: AbbVie Inc.

Bedrijfsleider
Beklede functiesVan
Robert Michael

Robert Michael

53 jaar

Chief Executive Officer 01-07-2024
Roopal Thakkar

Roopal Thakkar

Chief Tech/Sci/R&D Officer 01-01-2003
Kevin Buckbee

Kevin Buckbee

58 jaar

Comptroller/Controller/Auditor 01-03-2023
Perry Siatis

Perry Siatis

General Counsel 17-10-2022
Corporate Secretary 17-10-2022
Azita Saleki-Gerhardt

Azita Saleki-Gerhardt

60 jaar

Chief Operating Officer 01-07-2023
Scott Reents

Scott Reents

57 jaar

Director of Finance/CFO 23-06-2022
Tim Richmond

Tim Richmond

57 jaar

Human Resources Officer 01-01-2013
Todd D. Bosse

Todd D. Bosse

Investor Relations Contact 01-12-2021

Samenstelling van de raad van bestuur: AbbVie Inc.

Directeur
RadenVan
Richard Gonzalez

Richard Gonzalez

70 jaar

Chairman 01-01-2013
Glenn Tilton

Glenn Tilton

75 jaar

Executive Committee 30-04-2012
Compensation Committee 01-01-2013
HR Committee 04-05-2012
Governance Committee Chair 30-04-2012
Nominating Committee Chair 30-04-2012
Audit Committee
Governance Committee 01-01-2013
Nominating Committee 01-01-2013
Edward Rapp

Edward Rapp

66 jaar

Audit Committee 01-01-2013
Governance Committee Chair 01-01-2013
Nominating Committee Chair 01-01-2013
Compensation Committee 20-08-2021
Audit Committee Chair 20-08-2021
Rebecca Roberts

Rebecca Roberts

71 jaar

Compensation Committee 13-02-2015
Governance Committee Chair 01-01-2011
Governance Committee
Nominating Committee
Compensation Committee Chair
Roxanne Austin

Roxanne Austin

63 jaar

Compensation Committee Chair 01-01-2013
Audit Committee Chair 13-05-2021
Finance Committee 13-05-2021
Governance Committee Chair 26-05-2021
Nominating Committee Chair 26-05-2021
William Burnside

William Burnside

72 jaar

Executive Committee
Audit Committee 01-01-2013
Governance Committee 01-01-2013
Nominating Committee 01-01-2013
Frederick Waddell

Frederick Waddell

70 jaar

Executive Committee
Compensation Committee Chair
Audit Committee
Compensation Committee
Thomas Freyman

Thomas Freyman

69 jaar

Compensation Committee 08-05-2020
Audit Committee Chair 08-05-2020
Brett Hart

Brett Hart

54 jaar

Governance Committee 01-01-2016
Nominating Committee 01-01-2016
Melody Meyer

Melody Meyer

66 jaar

Compensation Committee
Audit Committee 01-01-2017
Jennifer Davis

Jennifer Davis

52 jaar

Governance Committee 11-10-2023
Nominating Committee 11-10-2023
Robert Alpern

Robert Alpern

73 jaar

Governance Committee
Nominating Committee
Robert Michael

Robert Michael

53 jaar

Director/Board Member 01-07-2024
Susan Quaggin

Susan Quaggin

Director/Board Member 11-10-2023
Independent Dir/Board Member 11-10-2023

Recente benoemingen: AbbVie Inc.

CSL Limited benoemt Elaine Sorg tot onafhankelijk niet-uitvoerend bestuurder, met ingang van 1 september 2024 CI
Fate Therapeutics, Inc. benoemt Neely Mozaffarian tot lid van de Raad van Bestuur CI
Abbvie kondigt benoeming aan van Roopal Thakkar tot Executive Vice President, Research & Development en Chief Scientific Officer CI
Merus benoemt nieuwe Chief Medical Officer MT
AbbVie zegt dat Robert Michael de rol van CEO overneemt MT
AbbVie kondigt wijzigingen in de Raad van Bestuur aan CI
AbbVie Inc. Kondigt wijzigingen in de Raad van Bestuur aan CI
Meer nieuws

Voormalige zaakvoerders en bestuurders: AbbVie Inc.

Insider
Beklede functies
VanTot
Thomas Hudson
Thomas Hudson
Chief Tech/Sci/R&D Officer 01-07-2019 10-07-2024
Corporate Officer/Principal 01-01-2016 01-07-2019
Katherine Rielly-Gauvin
Katherine Rielly-Gauvin
Corporate Officer/Principal 01-01-2013 01-07-2023
Frank Benenati
Frank Benenati
Public Communications Contact 01-04-2021 01-04-2023
Henry Gosebruch
Henry Gosebruch
Corporate Officer/Principal 01-12-2015 01-02-2023
Chris Boone
Chris Boone
Corporate Officer/Principal - 02-01-2023
Michael Gold
Michael Gold
Corporate Officer/Principal 01-05-2017 01-01-2023
Mohamed Zaki
Mohamed Zaki
Corporate Officer/Principal 01-09-2018 01-12-2022
Matthew Farber
Matthew Farber
Corporate Officer/Principal - 01-06-2022
Michael Severino
Michael Severino
Chief Tech/Sci/R&D Officer 01-06-2014 17-12-2018
President 17-12-2018 31-05-2022
Edward Liddy
Edward Liddy
Director/Board Member 01-01-2013 11-05-2022
Independent Dir/Board Member 01-01-2013 11-05-2022
Kate C. Liebelt
Kate C. Liebelt
Corporate Officer/Principal 01-06-2020 30-04-2022
Stuart Poulton
Stuart Poulton
Corporate Officer/Principal 01-01-2016 01-01-2022
Maryjo Chamberlain-Tharp
Maryjo Chamberlain-Tharp
Corporate Officer/Principal 01-09-2014 01-08-2021
Nataskia Lampe
Nataskia Lampe
Corporate Officer/Principal 01-03-2012 01-08-2021
Carlos Alban
Carlos Alban
Director/Board Member 17-12-2018 01-03-2021
Corporate Officer/Principal 01-01-2013 01-03-2021
Jose-Carlos Gutiérrez-Ramos
Jose-Carlos Gutiérrez-Ramos
Corporate Officer/Principal 01-02-2020 01-01-2021
Adelle Infante
Adelle Infante
Public Communications Contact - 01-12-2020
Janet Hammond
Janet Hammond
Corporate Officer/Principal 01-11-2016 01-08-2020
Lori-Ann Christie
Lori-Ann Christie
Private Equity Investor 01-05-2020 -
Vusi Moyo
Vusi Moyo
Public Communications Contact 01-04-2020 -
Ronald O. Robison
Ronald O. Robison
General Counsel 14-01-2013 -
Corporate Officer/Principal - 01-04-2020
Myra Rosario Herrle
Myra Rosario Herrle
Corporate Officer/Principal 01-08-2014 01-03-2020
Frank A. Jaeger
Frank A. Jaeger
Sales & Marketing 01-01-2014 01-08-2019
Scott Brun
Scott Brun
Corporate Officer/Principal - 01-03-2019
Nadia Dac
Nadia Dac
Corporate Officer/Principal 01-12-2014 01-03-2019
John Westwater
John Westwater
Director/Board Member 01-04-2018 31-12-2018
Jeffrey Stewart
Jeffrey Stewart
Corporate Officer/Principal - 01-12-2018
Jim Sullivan
Jim Sullivan
Private Equity Investor 01-01-2013 01-12-2018
Melanie Gloria
Melanie Gloria
Corporate Officer/Principal 01-08-2014 01-07-2018
Graig Suvannavejh
Graig Suvannavejh
Corporate Officer/Principal 01-03-2017 01-07-2018
Elizabeth Thompson
Elizabeth Thompson
Chief Tech/Sci/R&D Officer 01-09-2015 01-05-2018
Paul Peloso
Paul Peloso
Chief Tech/Sci/R&D Officer 01-12-2013 01-05-2018
Paul Schwichtenberg
Paul Schwichtenberg
Corporate Officer/Principal 01-10-2013 01-04-2018
Gary Gordon
Gary Gordon
Corporate Officer/Principal - 01-04-2018
Anil Singhal
Anil Singhal
Corporate Officer/Principal 01-07-2013 01-03-2018
Mark Stenhouse
Mark Stenhouse
Corporate Officer/Principal 01-10-2016 01-03-2018
Sujay Kango
Sujay Kango
Corporate Officer/Principal 01-01-2017 01-02-2018
Shao Lee Lin
Shao Lee Lin
Corporate Officer/Principal 01-04-2015 01-12-2017
Thomas A. Hurwich
Thomas A. Hurwich
Comptroller/Controller/Auditor - 28-02-2017
Sharon Curran
Sharon Curran
Corporate Officer/Principal 01-01-2012 01-01-2017
Ron Oyston
Ron Oyston
Human Resources Officer 01-01-2013 01-07-2016
Francisco Velasco
Francisco Velasco
Corporate Officer/Principal 01-06-2009 01-06-2016
Roy S. Roberts
Roy S. Roberts
Director/Board Member 01-01-2013 06-05-2016
Independent Dir/Board Member 01-01-2013 06-05-2016
Renee Tannenbaum
Renee Tannenbaum
Corporate Officer/Principal 01-10-2012 01-01-2016
Maria Rivas
Maria Rivas
Chief Tech/Sci/R&D Officer 01-08-2012 01-12-2015
Peter Heerma
Peter Heerma
Corporate Officer/Principal 01-12-2012 01-11-2015
David H. Donabedian
David H. Donabedian
Corporate Officer/Principal - 01-08-2015
Paul Wierbicki
Paul Wierbicki
General Counsel 01-03-2014 01-05-2015
Jennifer Mound Smoter
Jennifer Mound Smoter
Public Communications Contact 01-08-2012 01-03-2015
Barry Regan
Barry Regan
Chief Operating Officer 01-01-2013 01-03-2015
Alysa Spittle
Alysa Spittle
Public Communications Contact 01-01-2013 01-01-2015
Steven N. Gersten
Steven N. Gersten
Compliance Officer - 01-01-2015
Gary Winer
Gary Winer
Corporate Officer/Principal 01-04-2014 01-01-2015
Mohit Rawat
Mohit Rawat
Corporate Officer/Principal 01-08-2013 01-05-2014
Donald Frail
Donald Frail
Corporate Officer/Principal 01-01-2014 -
Lily Chang
Lily Chang
Private Equity Analyst 01-01-2013 01-01-2014
Lars Kielhorn
Lars Kielhorn
Corporate Officer/Principal 01-01-2011 01-01-2014
John Leonard
John Leonard
Chief Tech/Sci/R&D Officer 01-01-2013 01-01-2014
Jose Rivera
Jose Rivera
Compliance Officer 01-01-2013 01-09-2013
George Avgerinos
George Avgerinos
Corporate Officer/Principal 01-07-2008 01-07-2013
Laura Schumacher
Laura Schumacher
General Counsel 01-01-2013 -
Corporate Secretary 10-02-2014 17-10-2022
Greg W. Linder
Greg W. Linder
Director/Board Member - 31-12-2012
Sharon Greenlees
Sharon Greenlees
Investor Relations Contact 01-01-2016 01-01-2018
Corporate Officer/Principal 01-01-2018 -
Rita Jain
Rita Jain
Corporate Officer/Principal 01-01-2003 01-01-2012
Li Malmberg
Li Malmberg
Corporate Officer/Principal - -
Björn Cochlovius
Björn Cochlovius
Corporate Officer/Principal - -
Karl G. Trass
Karl G. Trass
Corporate Officer/Principal - -
Glenn S. Warner
Glenn S. Warner
Corporate Officer/Principal - -
Neil Gallagher
Neil Gallagher
President - -
Eduardo Bruno Martins
Eduardo Bruno Martins
Corporate Officer/Principal - -
David Laskow-Pooley
David Laskow-Pooley
Director/Board Member - -
Ann Tomlin
Ann Tomlin
Human Resources Officer - -
Christopher Kurtz
Christopher Kurtz
Corporate Officer/Principal - -
William Chase
William Chase
Chief Administrative Officer 19-10-2018 -
Director of Finance/CFO - 19-10-2018
Douglas Feltner
Douglas Feltner
Corporate Officer/Principal - -
Larry Peepo
Larry Peepo
Investor Relations Contact - -
Gregory Miley
Gregory Miley
Public Communications Contact - -
Denelle Waynick
Denelle Waynick
General Counsel - -
Kimberly Davis-Wells
Kimberly Davis-Wells
Corporate Officer/Principal - -
Karen Hale
Karen Hale
Compliance Officer - -
Saeed Motahari
Saeed Motahari
Corporate Officer/Principal - -
Youssef Bennani
Youssef Bennani
Corporate Officer/Principal - -
Star Seyedkazemi
Star Seyedkazemi
Corporate Officer/Principal - -
Jordan Dubow
Jordan Dubow
Corporate Officer/Principal - -
Joseph Lyssikatos
Joseph Lyssikatos
Director/Board Member - -
James P. Sullivan
James P. Sullivan
Corporate Officer/Principal - -
Derrell Porter
Derrell Porter
Sales & Marketing - -
Gentry Lassiter
Gentry Lassiter
Public Communications Contact - -
Barbara McGovern
Barbara McGovern
Corporate Officer/Principal - -
Paulo Vega
Paulo Vega
Corporate Officer/Principal - -
Rob Scott
Rob Scott
Chief Tech/Sci/R&D Officer - -

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man 20
Vrouw 7

Waarvan leden van het uitvoerend comité

Man 8
Vrouw 0

Waarvan bestuurders

Man 10
Vrouw 4
ESG Refinitiv
C+

Milieu

Emissies
Innovatie
Gebruik van middelen

Sociaal

Maatschappelijk engagement
Mensenrechten
Productaansprakelijkheid
HR

Bedrijfsvoering

MVO-strategie
Beheer
Aandeelhouders

Controverse

Controverse

Bedrijfsprofiel

Logo AbbVie Inc.
AbbVie Inc. is gespecialiseerd in onderzoek naar en ontwikkeling van therapeutische geneesmiddelen. Haar producten zijn bedoeld voor de behandeling van reumatoïde artritis, psoriasis, de ziekte van Crohn, schildklierziekte, de ziekte van Parkinson, HIV, complicaties van mucoviscidose, een laag testosteronniveau en complicaties die gepaard gaan met chronische nierziekte. De netto-omzet is als volgt geografisch verdeeld: Verenigde Staten (77,1%), Duitsland (2,3%), Canada (2%), Japan (1,9%), China (1,7%), Frankrijk (1,4%), Spanje ( 0,9%), Italië (0,9%), Australië (0,9%), Brazilië (0,8%), Verenigd Koninkrijk (0,8%) en overige (9,3%).
Werknemers
50.000
Sector
Farmaceutische producten
Agenda
23-10-2024 - BioProcess International Asia
Gerelateerde indices
S&P 500
Meer informatie over het bedrijf
  1. Beurs
  2. Aandelen
  3. Koers ABBV
  4. Onderneming AbbVie Inc.
  5. Bedrijfsvoering
-40 % Aanbod van beperkte duur: Onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU
Verenigde Staten

MarketScreener is also available in this country: United States.

Switch edition
Ik blijf hier.